Because BNectin-4 is a protein involved in cell–cell adhesion and is present at high levels in various malignant tumor cells [83,84], BNectin-4-targeting BT8009 can bind to Nectin-4 on breast cancer MDA-MB-468 cells and kill them [85]. Here, NECTIN4 is linked to cancer.